{
  "id": "64402bb057b1c7a315000043",
  "type": "factoid",
  "question": "In what type of clinical trial has RT001 been evaluated against Friedreich's ataxia?",
  "ideal_answer": "RT001 was evaluatd in a phase I/II double-blind, randomized, comparator-controlled trial in Friedreich's ataxia patients.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/29624723"
  ],
  "snippets": [
    {
      "text": "Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29624723",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "We conducted a phase I/II double-blind, comparator-controlled trial with 2 doses of RT001 in Friedreich's ataxia patients (9 subjects each cohort). ",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/29624723",
      "beginSection": "abstract",
      "endSection": "abstract"
    }
  ],
  "concepts": [],
  "exact_answer": "phase I/II double-blind, randomized, comparator-controlled trial"
}